Wells Fargo’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.73K Hold
2,235
﹤0.01% 6166
2026
Q1
$5.41K Sell
2,235
-2,250
-50% -$6.13K ﹤0.01% 6098
2025
Q4
$19.6K Sell
4,485
-5
-0.1% -$27 ﹤0.01% 5792
2025
Q3
$18.9K Hold
4,490
﹤0.01% 5809
2025
Q2
$12.9K Hold
4,490
﹤0.01% 5888
2025
Q1
$12.1K Hold
4,490
﹤0.01% 5851
2024
Q4
$10.6K Sell
4,490
-5
-0.1% -$13 ﹤0.01% 5926
2024
Q3
$10.7K Hold
4,495
﹤0.01% 5780
2024
Q2
$8.77K Sell
4,495
-4,984
-53% -$16.9K ﹤0.01% 5780
2024
Q1
$61K Buy
9,479
+994
+12% +$9.03K ﹤0.01% 5172
2023
Q4
$119K Sell
8,485
-27,528
-76% -$435K ﹤0.01% 4794
2023
Q3
$882K Buy
36,013
+32,335
+879% +$819K ﹤0.01% 3412
2023
Q2
$120K Buy
3,678
+2,660
+261% +$74.8K ﹤0.01% 4918
2023
Q1
$28.2K Buy
+1,018
New +$16.5K ﹤0.01% 5481

Other funds holding GNLX

Wells Fargo's GNLX Position: Q2 2026 in Review

Wells Fargo held its Genelux (GNLX) position steady in Q2 2026 at 2,235 shares worth $6.73K. The position accounts for ﹤0.01% of the portfolio, ranked #6166.

Wells Fargo first reported a position in GNLX in Q1 2023 and has held it in 14 quarters since. The position peaked at $882K in Q3 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Wells Fargo held 2,235 shares of Genelux worth $6.73K as of Q2 2026.
  • Wells Fargo left its Genelux share count unchanged in Q2 2026.
  • Genelux made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6166 holding.
  • Wells Fargo first reported a position in Genelux in Q1 2023 and has held it in 14 quarters since.
  • Wells Fargo's Genelux position peaked at $882K in Q3 2023.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.